Breaking News Instant updates and real-time market news.

MNK

Mallinckrodt

$69.16

-1.91 (-2.69%)

09:52
10/06/16
10/06
09:52
10/06/16
09:52

Mallinckrodt drops, levels to watch

Shares are down over 3.5% to $68.50. At that price next support is at $67.34. Resistance is at $69.56.

MNK Mallinckrodt
$69.16

-1.91 (-2.69%)

08/18/16
08/18/16
NO CHANGE

Mallinckrodt building new campus for Specialty Brands business in New Jersey
Mallinckrodt will build out a new campus for its Specialty Brands organizations in the Somerset Financial Center in Bedminster. Mallinckrodt will invest greater than $80M in New Jersey, and anticipates approximately 400 employees will occupy the new space in 1Q17. The company is also continuing its investment in St. Louis, Mo., having recently begun the next phase of construction at its downtown St. Louis manufacturing facility.
08/24/16
PIPR
08/24/16
NO CHANGE
Target $112
PIPR
Overweight
Mallinckrodt price target raised to $112 from $103 at Piper Jaffray
Piper Jaffray analyst David Amsellem said his talks with Mallinckrodt management indicate that the company's contracting activity is providing greater standardization of Acthar coverage and generally making the process of getting an Acthar prescription filled more predictable. In turn, this should make it more likely that physicians and practices will more consistently prescribe the drug, Amsellem tells investors. Paired with additional clinical outcomes data, Amsellem sees high visibility for relatively strong volume growth over the long-term and raised his price target on Mallinckrodt shares to $112 from $103 while keeping an Overweight rating on the stock.
08/26/16
UBSW
08/26/16
NO CHANGE
Target $92
UBSW
Buy
Skepticism on Acthar growth already priced into Mallinckrodt shares, says UBS
UBS analyst Marc Goodman said his investment thesis on Mallinckrodt remains unchanged, as he still sees an attractive valuation, has expectations its generics business will stabilize and believes that skepticism surrounding Acthar's growth is already priced into the stock. Goodman reiterated his Buy rating and $92 price target on Mallinckrodt shares.
09/21/16
MSCO
09/21/16
NO CHANGE
MSCO
Mallinckrodt's Ikaria acquisition underappreciated, says Morgan Stanley
Morgan Stanley analyst David Risinger said since the closing of the Ikaria acquisition, Mallinckrodt has quietly grown to be approximately 15% of 2017 estimates revenues and approximately 25% of 2017 estimated operating income. Given Ikaria's strong growth trends, Risinger estimates its valuation to be in the range of $3.9B-$4.3B, excluding Terlipressin pipeline asset, 78% more at the midpoint than Mallinckrodt's $2.3B purchase price.

TODAY'S FREE FLY STORIES

EONGY

E.ON

$10.98

-0.21 (-1.88%)

12:25
09/26/17
09/26
12:25
09/26/17
12:25
Hot Stocks
E.ON reaches pact with Fortum for right to tender Uniper stake »

E.ON SE said it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SXI

Standex

$105.10

1.15 (1.11%)

12:25
09/26/17
09/26
12:25
09/26/17
12:25
Conference/Events
Standex management to meet with Sidoti »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

FTR

Frontier Communications

$12.28

0.47 (3.98%)

12:25
09/26/17
09/26
12:25
09/26/17
12:25
Options
Frontier Communications call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SYT

Syngenta

$92.05

-0.03 (-0.03%)

12:18
09/26/17
09/26
12:18
09/26/17
12:18
Hot Stocks
Syngenta, plaintiffs reach pending settlement in corn traits litigation »

Plaintiffs and defendants…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

12:17
09/26/17
09/26
12:17
09/26/17
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

12:16
09/26/17
09/26
12:16
09/26/17
12:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMB

Williams

$30.44

-0.15 (-0.49%)

12:15
09/26/17
09/26
12:15
09/26/17
12:15
Options
Williams put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:15
09/26/17
09/26
12:15
09/26/17
12:15
General news
Breaking General news story  »

Atlanta Federal Reserve…

AAPL

Apple

$150.55

-1.34 (-0.88%)

, FIT

Fitbit

$6.54

0.1 (1.55%)

12:08
09/26/17
09/26
12:08
09/26/17
12:08
Hot Stocks
Apple, Fitbit among nine selected for FDA digital pilot program »

The Food and Drug…

AAPL

Apple

$150.55

-1.34 (-0.88%)

FIT

Fitbit

$6.54

0.1 (1.55%)

JNJ

Johnson & Johnson

$131.23

0.06 (0.05%)

RHHBY

Roche

$32.00

-0.02 (-0.06%)

SSNLF

Samsung

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 17

    Oct

  • 22

    Oct

  • 30

    Nov

  • 07

    Dec

  • 11

    Dec

OPK

OPKO Health

$6.87

0.16 (2.38%)

12:05
09/26/17
09/26
12:05
09/26/17
12:05
Options
Opko Health call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

PSO

Pearson

$7.78

-0.04 (-0.51%)

12:03
09/26/17
09/26
12:03
09/26/17
12:03
Downgrade
Pearson rating change  »

Pearson downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LGF.A

Lionsgate

$31.12

-0.16 (-0.51%)

12:02
09/26/17
09/26
12:02
09/26/17
12:02
Conference/Events
Lionsgate management to meet with Piper Jaffray »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 27

    Sep

  • 29

    Sep

LGF.A

Lionsgate

$31.12

-0.16 (-0.51%)

12:00
09/26/17
09/26
12:00
09/26/17
12:00
Conference/Events
Lionsgate management to meet with Piper Jaffray »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 29

    Sep

PDS

Precision Drilling

$3.11

0.02 (0.65%)

12:00
09/26/17
09/26
12:00
09/26/17
12:00
Conference/Events
Precision Drilling management to meet with Evercore ISI »

Group luncheon to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

LUXTY

Luxottica

$55.99

-0.36 (-0.64%)

12:00
09/26/17
09/26
12:00
09/26/17
12:00
Hot Stocks
EU opens in-depth probe into proposed Luxottica, Essilor merger »

The European Commission…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:55
09/26/17
09/26
11:55
09/26/17
11:55
Conference/Events
William Blair medical technology analyst holds analyst/industry conference call »

Medical Technology…

UBNT

Ubiquiti

$55.43

1.25 (2.31%)

11:55
09/26/17
09/26
11:55
09/26/17
11:55
Conference/Events
Ubiquiti to hold a conference call »

Chairman, Founder &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 28

    Nov

EA

Electronic Arts

$114.20

-4.3 (-3.63%)

11:50
09/26/17
09/26
11:50
09/26/17
11:50
Options
1.8K Electronic Arts Nov 115 - 125 call spreads for $3.25 »

1.8K Electronic Arts Nov…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IGT

International Game

$24.32

1.07 (4.60%)

11:45
09/26/17
09/26
11:45
09/26/17
11:45
Options
International Game call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:45
09/26/17
09/26
11:45
09/26/17
11:45
General news
Treasury's $35 B 4-week bill sale was on the soft side »

Treasury's $35 B…

AXON

Axovant Sciences

$24.25

-0.74 (-2.96%)

11:38
09/26/17
09/26
11:38
09/26/17
11:38
Recommendations
Axovant Sciences analyst commentary  »

JMP Securities keeps…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

HES

Hess Corp.

$46.00

-0.1 (-0.22%)

11:35
09/26/17
09/26
11:35
09/26/17
11:35
Options
Hess Corp. put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

11:35
09/26/17
09/26
11:35
09/26/17
11:35
General news
Breaking General news story  »

Federal Reserve Chair…

11:34
09/26/17
09/26
11:34
09/26/17
11:34
General news
4-Week Bill Auction Total Amount data reported »

4-Week Bill Auction Total…

RLJE

RLJ Entertainment

$3.38

-0.22 (-6.11%)

11:30
09/26/17
09/26
11:30
09/26/17
11:30
Conference/Events
RLJ Entertainment management to meet with MKM Partners »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.